To the full analysis
GSK stock: dividend
GSKGSK paid $1.82 per share over the last twelve months, 3.59% on the price, and has not cut its dividend for 4 years.
Daily figure as of 13 Nov 2026
Dividend yield over the last 12 months
3.59%
$1.82 per share over 12 months
Dividend per share 2025
$1.68
paid in fiscal 2025
45%
$3.11
covers the dividend of $1.68
Raised in a row
3 years
Years with a higher annual dividend than the year before
Growth 5 years
−4.4%
per year, from the last twelve months, without special dividends
Growth 10 years
−4%
per year, from the last twelve months, without special dividends
The yield is based on the dividends per security over the last 12 months and today's price. The figures for fiscal year 2025 come from the financial statements. For this security they are in a different currency than the price or apply per ordinary share, and with an ADR one security can stand for several shares. The two figures therefore cannot be compared directly.
Dividend dates and payments
Anyone holding the stock on the day before the ex-dividend date receives the dividend. Amounts are per share, before tax.
Last ex-dividend date
13 Nov 2026
$0.4518, paid 7 Jan 2027
Next ex-dividend date
not announced yet
Frequency
quarterly
Last cut: with the ex-dividend date 19 May 2022, the payment fell from $0.6220 to $0.3511 per share.
All 21 payments of the last five years
| Ex-dividend date | Payment date | Dividend per share |
|---|---|---|
| 13 Nov 2026 | 7 Jan 2027 | $0.4518 |
| 14 Aug 2026 | 8 Oct 2026 | $0.4501 |
| 15 May 2026 | 9 Jul 2026 | $0.4550 |
| 20 Feb 2026 | 9 Apr 2026 | $0.4776 |
| 14 Nov 2025 | 8 Jan 2026 | $0.4331 |
| 15 Aug 2025 | 9 Oct 2025 | $0.4300 |
| 16 May 2025 | 10 Jul 2025 | $0.4348 |
| 21 Feb 2025 | 10 Apr 2025 | $0.4007 |
| 15 Nov 2024 | 9 Jan 2025 | $0.3891 |
| 16 Aug 2024 | 10 Oct 2024 | $0.3857 |
| 16 May 2024 | 11 Jul 2024 | $0.3762 |
| 22 Feb 2024 | 11 Apr 2024 | $0.4061 |
| 16 Nov 2023 | 11 Jan 2024 | $0.3398 |
| 17 Aug 2023 | 12 Oct 2023 | $0.3613 |
| 18 May 2023 | 13 Jul 2023 | $0.3475 |
| 23 Feb 2023 | 13 Apr 2023 | $0.3419 |
| 17 Nov 2022 | 12 Jan 2023 | $0.3171 |
| 18 Aug 2022 | 6 Oct 2022 | $0.3910 |
| 19 May 2022 | 1 Jul 2022 | $0.3511 |
| 24 Feb 2022 | 7 Apr 2022 | $0.6220 |
| 18 Nov 2021 | 13 Jan 2022 | $0.5234 |
Dividend development
Dividend per share
Payout ratio
- of earnings
- of free cash flow
Figures as a table
| Year | Dividend per share | Earnings per share |
|---|---|---|
| 2006 | $1.52 | $3.15 |
| 2007 | $1.69 | $3.13 |
| 2008 | $1.92 | $2.94 |
| 2009 | $2.02 | $3.61 |
| 2010 | $2.09 | $1.06 |
| 2011 | $2.24 | $3.47 |
| 2012 | $2.57 | $3.05 |
| 2013 | $2.52 | $3.74 |
| 2014 | $2.65 | $1.91 |
| 2015 | $2.66 | $5.78 |
| 2016 | $3.31 | $0.64 |
| 2017 | $2.65 | $1.03 |
| 2018 | $2.65 | $2.44 |
| 2019 | $2.65 | $3.10 |
| 2020 | $2.65 | $3.82 |
| 2021 | $3.31 | $3.63 |
| 2022 | $2.81 | $9.85 |
| 2023 | $1.47 | $3.22 |
| 2024 | $1.59 | $1.67 |
| 2025 | $1.68 | $3.74 |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = £0.7544)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral since 13 Nov 2026, previously Strong
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.